WallStreetZenWallStreetZen

NASDAQ: IVVD
Invivyd Inc Stock

$4.00+0.34 (+9.29%)
Updated Mar 27, 2024
IVVD Price
$4.00
Fair Value Price
$0.82
Market Cap
$440.46M
52 Week Low
$0.98
52 Week High
$5.20
P/E
-2.58x
P/B
1.79x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$169.56M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.12
Operating Cash Flow
-$161M
Beta
1.31
Next Earnings
May 10, 2024
Ex-Dividend
N/A
Next Dividend
N/A

IVVD Overview

Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease. Adagio Therapeutics, Inc. has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies; and the Scripps Research Institute to perform research activities to identify vaccine candidates for the prevention, diagnosis or treatment of influenza or beta coronaviruses. The company was incorporated in 2020 and is based in Waltham, Massachusetts.

Zen Score

–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IVVD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IVVD ($4.00) is overvalued by 390.17% relative to our estimate of its Fair Value price of $0.82 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
IVVD ($4.00) is not significantly undervalued (390.17%) relative to our estimate of its Fair Value price of $0.82 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
IVVD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more IVVD due diligence checks available for Premium users.

Be the first to know about important IVVD news, forecast changes, insider trades & much more!

Valuation

IVVD fair value

Fair Value of IVVD stock based on Discounted Cash Flow (DCF)
Price
$4.00
Fair Value
$0.82
Overvalued by
390.17%
IVVD ($4.00) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
IVVD ($4.00) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
IVVD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

IVVD price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.58x
Industry
14.3x
Market
44.45x

IVVD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.79x
Industry
6.2x
IVVD is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IVVD's financial health

Profit margin

Revenue
$0.0
Net Income
-$39.4M
Profit Margin
0%
IVVD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$274.9M
Liabilities
$28.4M
Debt to equity
0.12
IVVD's short-term assets ($270.10M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IVVD's short-term assets ($270.10M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IVVD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$35.4M
Investing
$95.1M
Financing
$92.0k
IVVD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IVVD vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
IVVD$440.46M+9.29%-2.58x1.79x
CDMO$441.41M+2.80%-41.06x2.40x
OCS$436.50M+2.58%-3.53x4.10x
RVNC$435.78M+5.11%-1.29x-2.87x
JSPR$434.14M+3.33%-4.66x5.53x

Invivyd Stock FAQ

What is Invivyd's quote symbol?

(NASDAQ: IVVD) Invivyd trades on the NASDAQ under the ticker symbol IVVD. Invivyd stock quotes can also be displayed as NASDAQ: IVVD.

If you're new to stock investing, here's how to buy Invivyd stock.

What is the 52 week high and low for Invivyd (NASDAQ: IVVD)?

(NASDAQ: IVVD) Invivyd's 52-week high was $5.20, and its 52-week low was $0.98. It is currently -23% from its 52-week high and 308.16% from its 52-week low.

How much is Invivyd stock worth today?

(NASDAQ: IVVD) Invivyd currently has 110,114,960 outstanding shares. With Invivyd stock trading at $4.00 per share, the total value of Invivyd stock (market capitalization) is $440.46M.

Invivyd stock was originally listed at a price of $20.88 in Aug 6, 2021. If you had invested in Invivyd stock at $20.88, your return over the last 2 years would have been -80.84%, for an annualized return of -56.23% (not including any dividends or dividend reinvestments).

How much is Invivyd's stock price per share?

(NASDAQ: IVVD) Invivyd stock price per share is $4.00 today (as of Mar 27, 2024).

What is Invivyd's Market Cap?

(NASDAQ: IVVD) Invivyd's market cap is $440.46M, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Invivyd's market cap is calculated by multiplying IVVD's current stock price of $4.00 by IVVD's total outstanding shares of 110,114,960.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.